Cytomedix is well positioned to achieve a leadership position in the field of advanced tissue regeneration technologies, with the continuing development and marketing of biologically active products to treat patients with debilitating and life-threatening conditions. Our synergistic Angel® and AutoloGel products place Cytomedix as a leader in PRP technology with FDA indications in the areas of orthopedics and wound care. Both product lines have proven clinical benefits and significant growth potential.